AzTrials
AzTrials

Cognitive TherapyNCT02859051

MEDi Robot for Pain Management at Induction

A study testing Humanoid Robot MEDi in people with Cognitive Therapy, run by University of Calgary at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine if a preparation teaching intervention before IV insertion, taught by MEDi to children and their parents, will lead to lower levels of expected and experienced pain and fear and less distressing pain memories, as compared to children who receive standard care. Read more about this study

Who is it for?
Ages 4 to 12 years
Conditions the study is for
Cognitive Therapy
What is being tested?
Humanoid Robot MEDi
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
137 participants
Where
1 siteCanada
Study dates
8 Jul 2016to 25 May 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 4 to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • presenting for general surgery under general anesthesia, and in the American Society of Anesthesiologists class 1 or 2

Who cannot join

  • patient presenting for day surgery
  • patient requires an intravenous placed in day surgery unit
  • patient cognitively unable to self-report pain
  • patient with a hearing or visual impairment or developmental disability that precludes self-reporting ability
  • family or child that is unable to communicate in English
  • previous allergic reaction to propofol or lidocaine

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • Alberta Children's Hospital

    Calgary, Alberta, T3B 6A8

Other trials in Canada

About this study

Official title: Efficacy of a Preparation Intervention for the Management of Children's Pain and Fear During Induction: Help From a Robot Named MEDi

The purpose of this study is to determine if a preparation teaching intervention before IV insertion, taught by MEDi to children and their parents, will lead to lower levels of expected and experienced pain and fear and less distressing pain memories, as compared to children who receive standard care. In addition, it will be examined whether this preparation intervention will lead to greater parental self-efficacy, less anxiety, and less distressing pain memories as compared to controls.

Read the detailed description

The primary aim is to determine the impact of using a humanoid robot in comparison to standard care. This proposal describes the first study in the world to test such novel technology for preparation teaching intervention before IV insertion. This work builds on previous research conducted by the research team and represents a logical next step for this collaborative group. This project team includes established and emerging leaders in pain management research. This will ensure successful implementation and completion of the project. These methods of teaching preparation have the potential for widespread application to other medical procedures and clinical settings (eg. oncology dentistry) and lead to improved health outcomes for children by easing their suffering and improving the quality of their healthcare encounters.

1.2 Research Questions

Research Question 1.) Does preparation administered by a humanoid robot (MEDi) reduce expectancies and experience of pain and fear of IV insertion in children?

Hypothesis 1.) Children who receive preparation by MEDi will report expecting and experiencing lower levels of fear and pain at IV insertion as compared to youth receiving standard care.

Research Question 2.) Does preparation administered by MEDi lead to higher self-efficacy and lower anxiety in parents of children undergoing IV insertion?

Hypothesis 2.) Parents of children who receive preparation by MEDi will report higher levels of self-efficacy and lower anxiety at their children's IV insertion as compared to youth receiving standard care.

Research Question 3.) Do children who receive preparation administered by MEDi and their parents have more accurate and positively estimated memories of pain and fear as compared to youth receiving standard care and their parents?

Hypothesis 3.) Children who receive preparation administered by MEDi and their parents will report more accurate and positively estimated memories of pain and fear as compared to youth receiving standard care and their parents.

Research Question 4.) Do children who receive preparation administered by MEDi prior to IV insertion and their parents expect to experience less pain, fear, anxiety, and higher self-efficacy in pain coping at future needle procedures as compared to youth receiving standard care and their parents?

Hypothesis 4.) Children who receive preparation administered by MEDi prior to IV insertion and their parents will report expecting to experience lower pain, fear, and anxiety and higher self-efficacy in pain coping at future needle procedures as compared to youth receiving standard care and their parents.

2.1 Study Design \& Setting

This study is a single-centre prospective randomized, controlled, two-armed trial: (1) humanoid robot, MEDi, provides preparation for intravenous placement; and (2) standard care. Patients will be recruited from day surgery at the Alberta Children's Hospital Calgary, AB. This study will follow the high methodological standards for reporting RCTs according to the Consolidated Standards of Reporting Trials guidelines - extension for nonpharmacological treatments and this trial will be registered with clinicaltrials.gov.

2.2. Study Population

Legal guardians and/or patients with the ability to understand the study will be asked to provide written informed consent prior to participation. Day surgery patients, between the ages of 4-12 years old who are presenting for general surgery under general anesthesia, and in the American Society of Anesthesiologists class 1 or 2, will be included.

Being tested
Humanoid Robot MEDi
Keywords
Cognitive Behavioral Support provided by Robot

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Humanoid Robot MEDiDevice

    Humanoid robot programmed with cognitive-behavioral interventions such as role modeling, teaching coping strategies, positive reinforcement, parent encouragement

Study groups in NCT02859051
Study groupRoleWhat they receive
controlNo interventionNo intervention
robotExperimentalHumanoid robot interacts with child, teaching breathing and coping strategies.
Receives: Device: Humanoid Robot MEDi

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. child's pain

    Faces Pain Scale-Revised (FPS-R) (Hicks, 2001)

    Measured: at moment of child's IV start

Secondary outcomes (5)
  1. child's fear

    Children's Fear Scale (McMurtry, Noel, Chambers, \& McGrath, 2011)

    Measured: at the moment of OR entry

  2. parent self-efficacy

    use 0-10 numerical rating scales to report the degree to which they feel self-efficacy in their ability to help their child manage their pain and fear

    Measured: 30 mins to 3 hours before induction

  3. parent anxiety

    Parents will be asked to report on their own level of anxiety during the needle procedure using a 0-10 NRS ranging from 0 ('not at all nervous or anxious') to 10 ('most nervous or anxious').

    Measured: 30 mins to 3 hours before induction

  4. children's memory

    , parents and children will be asked to provide their free recall of each of those periods using open-ended prompts

    Measured: 2 weeks after child's induction

  5. parents' memory

    , parents and children will be asked to provide their free recall of each of those periods using open-ended prompts

    Measured: 2 weeks after child's induction

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Aug 2016 (estimated)
  2. Study start8 Jul 2016
  3. Primary completion25 May 2018
  4. Study completion25 May 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
137 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02859051
Sponsor's protocol ID
REB16-0148
Status last verified
Apr 2021
First submitted
28 Jul 2016
Last updated
27 Apr 2021
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Humanoid Robot MEDi in people with Cognitive Therapy, run by University of Calgary at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Apr 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

child's pain (time frame: at moment of child's IV start). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Apr 2021.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in